Literature DB >> 3112151

The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activation.

A A Davies, D A Cantrell, J M Hexham, P J Parker, J Rothbard, M J Crumpton.   

Abstract

The gamma subunit of the human T lymphocyte T3 antigen is rapidly phosphorylated on serine residues in vivo during the initiation of T cell activation by a polyclonal mitogen (Phaseolus vulgaris phytohemagglutinin), an activator of protein kinase C (phorbol 12,13-dibutyrate), and an elevator of intracellular calcium (ionomycin). The sites of phosphorylation were identified by comparing tryptic peptide analyses of T3 gamma chains labeled in vivo with various synthetic peptides, corresponding to portions of the cytoplasmic domain of the gamma chain that had been labeled in vitro using purified protein kinase C. Two sites, serines 123 and 126, were phosphorylated in response to ionomycin, whereas a single site, serine 126, was phosphorylated when T lymphocytes were stimulated by P. vulgaris phytohemagglutinin or when protein kinase C was directly activated by phorbol 12,13-dibutyrate. Immune activation of T cells via the protein kinase C pathway thus induces phosphorylation of a single site on the T3 gamma chain, namely serine 126.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3112151

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  CD3 and CD2 antigen-mediated CD3 gamma-chain phosphorylation in permeabilized human T cells. Regulation by cytosolic phosphatases.

Authors:  D R Alexander; M H Brown; A L Tutt; M J Crumpton; E Shivnan
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

2.  T-cell receptor stimulation elicits an early phase of activation and a later phase of deactivation of the transcription factor NFAT1.

Authors:  C Loh; J A Carew; J Kim; P G Hogan; A Rao
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

3.  CD4-T-cell antigen receptor complexes on human leukemia T cells.

Authors:  R S Chuck; C R Cantor; D B Tse
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Respective contribution of intracellular calcium release and extracellular calcium influx for interleukin-2 synthesis in activated T-cell hybrids.

Authors:  D B Williams; M A Perera; K J Dorrington; M H Klein
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

5.  A method for measuring protein kinase C activity in permeabilized T lymphocytes by using peptide substrates. Evidence for multiple pathways of kinase activation.

Authors:  D R Alexander; J D Graves; S C Lucas; D A Cantrell; M J Crumpton
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

6.  Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases.

Authors:  J S Nixon; S E Wilkinson; P D Davis; A D Sedgwick; J Wadsworth; D Westmacott
Journal:  Agents Actions       Date:  1991-03

7.  The association of type 1, type 2A and type 2B phosphatases with the human T lymphocyte plasma membrane.

Authors:  D R Alexander; J M Hexham; M J Crumpton
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

8.  A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O-permeabilized human T lymphocytes.

Authors:  D R Alexander; J M Hexham; S C Lucas; J D Graves; D A Cantrell; M J Crumpton
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

9.  Adhesion molecules of cultured hematopoietic malignancies. A calcium-dependent lectin is the principle mediator of binding to the high endothelial venule of lymph nodes.

Authors:  L M Stoolman; H Ebling
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

10.  CD3 gamma contains a phosphoserine-dependent di-leucine motif involved in down-regulation of the T cell receptor.

Authors:  J Dietrich; X Hou; A M Wegener; C Geisler
Journal:  EMBO J       Date:  1994-05-01       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.